Sorting out the cephalosporins

References

• Third-generation cephalosporins: a decade of progress in the treatment of severe infections. Am J Med 1990: 88(4A): 1–45S
   PubMed Web of Science ®Google Scholar
• Donowitz GR, Mandell GL. Beta-lactam antibiotics. 1. N Engl J Med 1988: 318(7): 419–26
   PubMed Web of Science ®Google Scholar
• Donowitz GR, Mandell GL. Beta-lactam antibiotics. 2. N Engl J Med 1988: 318(8): 490–500
   PubMed Web of Science ®Google Scholar
• Agnelli G, Del Faveto A, Parise P, et al. Cephalosporin-induced hypoprothrombinemia: is the N-methylthiotetrazole side chain the culprit? Antimicrob Agents Chemother 1986: 29(6): 1108–9
   PubMed Web of Science ®Google Scholar
• Jones R. Hemorrhagic complications of cephalosporin therapy. Antimicrob Newsletter 1989: 5(12): 85–8
   Google Scholar
• Grasela TH Jr, Walawander CA, Welage LS, et al. Prospective surveillance of antibiotic-associated coagulopathy in 970 patients. Pharmacotherapy 1989: 9(3): 158–64
   PubMed Web of Science ®Google Scholar
• Fried JS, Hinthorn DR. The cephalosporins. Dis Mon 1985: 31(7): 1–60
   PubMed Web of Science ®Google Scholar
• McCracken GH Jr, Nelson JD, Kaplan SL, et al. Consensus report: antimicrobial therapy for bacterial meningitis in infants and children. Pediatr Infect Dis J 1987: 6(6): 501–5
   PubMed Web of Science ®Google Scholar
• Odio CM, Faingezicht I, Salas JL, et al. Cefotaxime vs conventional therapy for the treatment of bacterial meningitis of infants and children. Pediatr Infect Dis 1986: 5(4): 402–7
   PubMedGoogle Scholar
• Yogev R, Shulman ST, Chadwick EG, et al. Once daily ceftriaxone for central nervous system infections and other serious pediatric infections. Pediatr Infect Dis 1986: 5(3): 298–303
   PubMedGoogle Scholar
• Prado V, Cohen J, Banfi A, et al. Ceftriaxone in the treatment of bacterial meningitis in children. Chemotherapy 1986: 32(4): 383–90
   PubMed Web of Science ®Google Scholar
• Marks WA, Stutman HR, Marks MI, et al. Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: a multicenter randomized controlled trial. J Pediatr 1986: 109(1): 123–30
   PubMed Web of Science ®Google Scholar
• Smith MA, Ryan ME. Cephalosporin therapy for childhood meningitis. Am Fam Physician 1989: 36(3): 185–92
   Web of Science ®Google Scholar
• Glatt AE. Second-generation cephalosporins. Hosp Pract (Off) 1986: 21(3): 158A–B, E, H–L
   PubMed Web of Science ®Google Scholar
• Mandell GL. Cephalosporins. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and practice of infectious disease. New York: Longman (Churchill Livingstone), 1990: 246–57
   Google Scholar
• Eichenwald HF, Schmitt HJ. The cephalosporin antibiotics in pediatric therapy. Eur J Pediatr 1986: 144(6): 532–8
   PubMed Web of Science ®Google Scholar
• Goldberg DM. The cephalosporins. Med Clin North Am 1987: 71(6): 1113–33
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. 1989 sexually transmitted diseases treatment guidelines. MMWR 1989: 38(Suppl 8): 1–43 [erratum, MMWR 1989: 38(38): 664]
   PubMedGoogle Scholar
• Gleckman RA, Bergman MM. When to tum to the newer cephalosporins. J Respir Dis 1986: 7(12): 51–7
   Google Scholar
• Shurin PA, Marchant CD, Kim CH, et al. Emergence of beta-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media. Pediatr Infect Dis 1983: 2(1): 34–8
   PubMedGoogle Scholar
• Carlin SA, Marchant CD, Shurin PA, et al. Early recurrences of otitis media: reinfection or relapse? J Pediatr 1987: 110(1): 20–5 [erratum, J Pediatr 1987: 110(4): 668]
   PubMed Web of Science ®Google Scholar
• Doern GV. Branhamella catarrhalis: a significant human pathogen. Infect Med 1987: Jul/Aug: 257–60
   Google Scholar
• PDR drug interactions and side effects index. 44th ed Oradell, NJ: Medical Economics, 1990
   Google Scholar
• Brown RB, Mar J, Lemeshow S, et al. Enhanced bleeding with cefoxitin or moxalactam: statistical analysis within a defined population of 1493 patients. Arch Intern Med 1986: 146(11): 2159–64
   PubMedGoogle Scholar
• Donowitz GR. Third generation cephalosporins. Infect Dis Clin North Am 1989: 3(3): 595–612
   PubMedGoogle Scholar
• The choice of antimicrobial drugs. Med Lett Drugs Ther 1990: 32(817): 41–8
   PubMedGoogle Scholar
• Rodriguez WJ, Puig JR, Khan WN, et al. Ceftazidime vs standard therapy for pediatric meningitis: therapeutic, pharmacologic and epidemiologic observations. Pediatr Infect Dis 1986: 5(4): 408–15
   PubMedGoogle Scholar
• Steele RW, Kearns GL. Antimicrobial therapy for pediatric patients. Pediatr Clin North Am 1989: 36(5): 1321–49
   PubMed Web of Science ®Google Scholar
• Congeni BL, Bradley J, Hammerschlag MR. Safety and efficacy of once daily ceftriaxone for the treatment of bacterial meningitis. Pediatr Infect Dis 1986: 5(3): 293–7 [erratum, Pediatr Infect Dis 1986: 5(5): 508]
   PubMedGoogle Scholar
• Schaad UB, Suter S, Gianella-Borradori A, et al. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. N Engl J Med 1990: 322(3): 141–7
   PubMed Web of Science ®Google Scholar
• Pigrau C, Pahissa A, Gropper S, et al. Ceftriaxone-associated biliary pseudolithiasis in adults. (Letter) Lancet 1988: 2(8625): 1411–3
   PubMed Web of Science ®Google Scholar
• Lee SP, Lipsky BA, Teefey SA. Gallbladder sludge and antibiotics. Pediatr Infect Dis J 1990: 9(6): 422–3
   PubMed Web of Science ®Google Scholar
• Sauerwein M, Deamer RL, Prichard JG. Use of long half-life parenteral cephalosporins in ambulatory practice. J Fam Pract 1987: 24(1): 47–51
   PubMed Web of Science ®Google Scholar
• Boskgo JW Tramont EC, Takafuji ET, et al. Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae. N Engl J Med 1987: 317(5): 272–8
   PubMed Web of Science ®Google Scholar
• Treatment of Lyme disease. Med Lett Drugs Ther 1989: 31(794): 57–9
   PubMedGoogle Scholar
• Hatch D, Overturf GD, Kovacs A, et al. Treatment of bacterial meningitis with ceftazidime. Pediatr Infect Dis 1986: 5(4): 416–20
   PubMedGoogle Scholar
• McCue JD. Cost-conscious use of the cephalosporins: a guide to empiric therapy. New York: Raven Health Care Communications, 1986
   Google Scholar
• Smith KS, Briceland LL, Nightingale CH, et al. Formulary conversion of cefoxitin usage to cefotetan: experience at a large teaching hospital. DICP 1989: 23(12): 1024–30
   PubMedGoogle Scholar
• Cefixime: a new oral cephalosporin. Med Lett Drugs Ther 1989: 31(798): 73–6
   PubMed Web of Science ®Google Scholar